MajorSynthetic opioid, full mu-receptor agonist×Other opioids
Updated · Methodology
Mechanism
Tramadol and methadone are both opioids, and their depressant effects on the central nervous system (CNS) and breathing add up. The tramadol SmPC lists other opioids and substitution treatment among CNS depressants that raise the risk of sedation, respiratory depression, coma and death (tramadol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The methadone SmPC includes opioid analgesics among sedatives that increase respiratory and CNS depression and lower blood pressure (methadone SmPC, AEMPS). Methadone is eliminated slowly and accumulates (methadone SmPC, AEMPS). The second mechanism is serotonergic. The US methadone label lists tramadol among drugs that affect the serotonin system and have caused serotonin syndrome when used with opioids (methadone label, US Food and Drug Administration, FDA). Tramadol can cause seizures, and the seizure risk is higher when it is used with other opioids (tramadol label, FDA).
Symptoms
Signs include sleepiness, confusion, shallow breathing, pinpoint pupils, nausea, vomiting and low blood pressure. In severe cases, respiratory and circulatory depression, coma and death can occur (tramadol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS; methadone SmPC, AEMPS). Because methadone accumulates, respiratory depression can appear 1–2 weeks after a methadone dose increase (methadone SmPC, AEMPS). Signs of serotonin syndrome include agitation, hallucinations, tachycardia, labile blood pressure, fever, hyperreflexia, incoordination, muscle rigidity, nausea, vomiting and diarrhoea. They usually appear within hours to a few days of combined use (tramadol label, US Food and Drug Administration, FDA). Tramadol can cause seizures even at recommended doses, and other opioids increase this risk (tramadol label, FDA).
Management
Prescribe two opioids together only when other treatment options are inadequate, at the lowest effective dose and for the shortest time (tramadol and methadone SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS; tramadol and methadone labels, US Food and Drug Administration, FDA). When methadone is started for pain, the US methadone label says to stop all other opioid analgesics, except those used as needed for breakthrough pain (methadone label, FDA). In opioid dependence, use tramadol only with special caution. It is not a suitable substitute in people with opioid dependence and does not suppress morphine withdrawal symptoms. It is contraindicated for the treatment of opioid withdrawal (tramadol SmPC, AEMPS). If a person on methadone maintenance for opioid dependence has acute pain, the usual methadone dose will not relieve it. The US methadone label advises analgesics, including opioids, at the doses normally used for such pain. Because of tolerance, somewhat higher or more frequent doses are often needed (methadone label, FDA). Do not exceed 400 mg of tramadol per day (tramadol label, FDA). The Spanish SmPC allows more only in special clinical circumstances, and above this dose the seizure risk may rise (tramadol SmPC, AEMPS). Methadone accumulates, so respiratory depression can appear 1–2 weeks after each dose increase. With other central nervous system depressants, the dose of one or both drugs may need to be reduced (methadone SmPC, AEMPS). Monitor the patient closely for respiratory depression and sedation, and warn the patient and carers about these signs (tramadol and methadone SmPCs, AEMPS). The US labels advise considering an opioid overdose reversal agent, such as naloxone (tramadol and methadone labels, FDA). At the start of combined use and after dose changes, check the patient often for signs of serotonin syndrome. If serotonin syndrome is suspected, stop methadone and tramadol (methadone label, FDA; tramadol label, FDA).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- FDA: Tramadol hydrochloride tablets prescribing information (Amneal) (2026)– FDA label, Amneal Pharmaceuticals NY LLC, DailyMed setid 8ec4e4e5-a56e-4198-8428-6b770b9bf27d, revised 06/2026, sections 4, 5.9, 5.10, 7 and 17
- AEMPS: Ficha técnica: Metadona (Metasedin 40 mg) (nº registro 62423), secciones 4.4 y 4.5 (2026)– AEMPS, CIMA, nº registro 62423, revisión 05/2026, secciones 4.4 y 4.5
- AEMPS: Ficha técnica: Tramadol, Adolonta 50 mg cápsulas (nº registro 59088), sección 4.5 (2025)– AEMPS, CIMA, nº registro 59088, revisión 11/2025, secciones 4.2, 4.4 y 4.5
- FDA: Methadone hydrochloride tablets (methadone) prescribing information (2025)– FDA, DailyMed setid 4a44bde6-c348-4316-b0e0-c24b407cb823 (VistaPharm), versión 17, revisión 12/2025, secciones 5.4, 5.9 y 7
- AEMPS: Ficha técnica: Tramadol, Adolonta 50 mg cápsulas (nº registro 59088), sección 4.3 (2025)– AEMPS, CIMA, nº registro 59088 (Adolonta 50 mg cápsulas duras, Grünenthal Pharma), revisión 11/2025 (texto revisado 10/2025), secciones 4.3, 4.4, 4.5 y 5.1